基于慢性血栓栓塞性肺高血压的5个枢纽基因的新诊断模型的识别
Feng Zhang1, Xiaoming Huang2, Junqi Lin2
1Department of Intensive Care Unit, The First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Current medicinal chemistry
|June 7, 2023
概括
研究人员确定了五个与氧化压力相关的枢纽基因,这可能有助于诊断慢性血栓栓塞性肺高血压 (CTEPH). 这一发现为预测CTEPH预后提供了潜在的生物标志物.
科学领域:
- 基因组学和生物信息学
- 肺高血压研究 肺高血压研究
- 生物标志物发现发现
背景情况:
- 慢性血栓栓塞性肺高血压 (CTEPH) 是由未解决的肺栓塞引起的前毛囊性肺高血压.
- 确定预后生物标志物对于管理CTEPH患者至关重要.
研究的目的:
- 确定用于预测慢性血栓栓塞性肺高血压 (CTEPH) 预后的新生物标志物基因.
主要方法:
- 使用生物信息学工具分析了来自CTEPH患者的RNA测序数据.
- 鉴定了差异表达基因 (DEGs) 和小RNA (DEMs).
- 分析了基因表达,miRNA-mRNA网络,蛋白质-蛋白质相互作用网络和免疫透.
- 使用支持矢量机 (SVM) 算法开发了一个诊断模型.
主要成果:
- 在CTEPH样本中,氧化应激反应得分较低.
- 在CTEPH和正常样本中发现了628个DEG和31个DEM.
- 确定了五个与免疫细胞得分和氧化应激正相关的枢纽基因.
- 一个基于这五个枢纽基因的诊断模型表明了对CTEPH的良好诊断能力.
结论:
- 与氧化应激相关的五个枢纽基因被确定为CTEPH的潜在生物标志物.
- 这些基因可能对诊断CTEPH和预测患者预后有好处.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
234
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
234
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
Pulmonary Embolism I: Introduction
10
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
10
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17


